Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 30, 2015
Piramal Enterprises' Pharma Solutions division, a global contract development and manufacturing (CDMO) company, has set a target of becoming the market leader in ADCs contract commercialization over the next five years.
read more
Thursday, November 17, 2022
Piramal Critical Care (PCC) has integrated its sustainability framework with its strategy as well as daily business practices.
read more
Piramal Critical Care announced the launch of MITIGO™ (Morphine Sulfate Injection, USP – Preservative-free) in 10 mg/mL and 25 mg/mL concentrations in the U.S. market.
read more
Piramal Critical Care, an integral business unit of Piramal Enterprises Limited and Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology, have officially launched a co-promotion of ...
read more
Piramal Pharma Limited’s Piramal Critical Care (PCC) business announced the appointment of Jeffrey Hampton as President & Chief Operating Officer (COO). For his new role, Mr. Hampton will be based in the United States.
read more
Tuesday, October 10, 2017
Piramal announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities.
read more
Piramal is providing Bolt with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt's ongoing Phase 1/2 clinical study in cancer patients.
read more
Wednesday, September 16, 2026
Piramal Pharma Solutions is installing a 4.3-MWp ground-mounted solar power plant at its integrated drug-substance and drug-product facility in Morpeth, United Kingdom.
read more
Tuesday, September 17, 2013
Piramal | Healthcare today announced that it is to invest 11 million USD at its Morpeth, UK facility to triple the production capacity for hormonal products, including contraceptive pills and hormone replacement therapies. The expansion, which has ...
read more
Pinnaql, Inc. has acquired Pharma Resource Group, Inc. (PRG), a specialized consulting firm with nearly 20 years of experience supporting pharmaceutical and biotechnology companies in the U.S. and internationally.
read more
Pinnaql has acquired Validation & Engineering Group, Inc. (VEG), a provider of commissioning, qualification, and validation (CQV) services to the pharmaceutical and life sciences industries.
read more
Certara, a global leader in biosimulation, announced that the FDA awarded a five-year contract with Pinnacle 21 for ongoing software and related services support for the agency’s DataFit program. The DataFit program assesses data quality and performs...
read more
An Ottawa Valley-based pharmaceutical company is planning to expand its operations after receiving money from the provincial government as part of a funding program designated for eastern Ontario.
read more
Wednesday, September 11, 2024
Pillar Biosciences, Inc. has entered into a strategic partnership with AstraZeneca to expand laboratory access to molecular testing, using rapid, Next Generation Sequencing (NGS)-based liquid biopsy tumor profiling panels for detection of genetic ...
read more
Tuesday, November 20, 2018
As part of Pilatus Comparator Solutions' ongoing plans to strengthen its Global footprint, the company has announced that their Long Island Facility is now fully licensed and operational.
read more